Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Etanercept in Patients With Moderate to Severe Plaque Psoriasis Who Have Shown an Unsatisfactory Response to Adalimumab or Infliximab

NCT00967538 is registered in ClinicalTrials.gov with Innovaderm Research Inc. as lead sponsor.

NCT NCT00967538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00967538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Etanercept in Patients With Moderate to Severe Plaque Psoriasis Who Have Shown an Unsatisfactory Response to Adalimumab or Infliximab
Lead sponsor
Innovaderm Research Inc.
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2009
Completion date
July 31, 2014
Enrollment
89 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis